Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Dierich

Showing results (311-320 of 337) with videos related to

Pageof 34
Sort By:
European Journal of Biochemistry|February 1, 1994
Expression of properdin in human monocytesW Schwaeble, H P Huemer, J Möst, et al.
FEBS Letters|April 19, 1993
Neopterin modulates toxicity mediated by reactive oxygen and chloride speciesG Weiss, D Fuchs, A Hausen, et al.
Immunology Letters|August 1, 1989
HIV and HIV-infected cells differentially activate the human complement system independent of antibodyB M Sölder, T F Schulz, P Hengster, et al.
Arzneimittel-Forschung|August 1, 1989
Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cellsG Bitterlich, C Larcher, B Sölder, et al.
Clinical Chemistry|December 1, 1988
Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1D Fuchs, M Banekovich, A Hausen, et al.
British Journal of Haematology|May 1, 2001
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignanciesC Lass-Flörl, J Aigner, E Gunsilius, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDSD Fuchs, A Hausen, E Hoefler, et al.
Immunobiology|October 26, 1999
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitorsA Gruber, J Berlit, C Speth, et al.
AIDS (London, England)|March 1, 1989
Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infectionsT F Schulz, W Oberhuber, J M Hofbauer, et al.
Molecular Immunology|August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?H Stoiber, I Frank, M Spruth, et al.
Pageof 34

Showing results (311-320 of 337) with videos related to

Sort By:
Pageof 34
European Journal of Biochemistry|February 1, 1994
Expression of properdin in human monocytesW Schwaeble, H P Huemer, J Möst, et al.
FEBS Letters|April 19, 1993
Neopterin modulates toxicity mediated by reactive oxygen and chloride speciesG Weiss, D Fuchs, A Hausen, et al.
Immunology Letters|August 1, 1989
HIV and HIV-infected cells differentially activate the human complement system independent of antibodyB M Sölder, T F Schulz, P Hengster, et al.
Arzneimittel-Forschung|August 1, 1989
Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cellsG Bitterlich, C Larcher, B Sölder, et al.
Clinical Chemistry|December 1, 1988
Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1D Fuchs, M Banekovich, A Hausen, et al.
British Journal of Haematology|May 1, 2001
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignanciesC Lass-Flörl, J Aigner, E Gunsilius, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDSD Fuchs, A Hausen, E Hoefler, et al.
Immunobiology|October 26, 1999
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitorsA Gruber, J Berlit, C Speth, et al.
AIDS (London, England)|March 1, 1989
Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infectionsT F Schulz, W Oberhuber, J M Hofbauer, et al.
Molecular Immunology|August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?H Stoiber, I Frank, M Spruth, et al.
Pageof 34